(31) P MR spectroscopic imaging of the human prostate at 7 T: T1 relaxation times, Nuclear Overhauser Effect, and spectral characterization

Magn Reson Med. 2015 Mar;73(3):909-20. doi: 10.1002/mrm.25209. Epub 2014 Mar 26.

Abstract

Purpose: Optimization of phosphorus ((31) P) MR spectroscopic imaging (MRSI) of the human prostate at 7 T by the evaluation of T1 relaxation times and the Nuclear Overhauser Effect (NOE) of phosphorus-containing metabolites.

Methods: Twelve patients with prostate cancer and one healthy volunteer were scanned on a 7 T whole-body system using a (31) P endorectal coil combined with an eight-channel (1) H body array coil. T1 relaxation times were measured using progressive saturation in a two-dimensional localization sequence. (31) P MRSI was performed twice: once without NOE and once with NOE using low-power continuous wave (1) H irradiation to determine NOE enhancements.

Results: T1 relaxation times of (31) P metabolites in the human prostate at 7 T varied between 3.0 and 8.3 s. Positive but variable NOE enhancements were measured for most metabolites. Remarkably, the (31) P MR spectra showed two peaks in chemical shift range of inorganic phosphate.

Conclusion: Knowledge of T1 relaxation times and NOE enhancements enables protocol optimization for (31) P MRSI of the prostate at 7 T. With a strongly reduced (31) P flip angle (≤ 45°), a (31) P MRSI dataset with optimal signal-to-noise ratio per unit time can be obtained within 15 minutes. The NOE enhancement can improve fitting accuracy, but its variability requires further investigation.

Keywords: 31P MR spectroscopic imaging; 7 Tesla; magnetic field strength; Nuclear Overhauser Effect; T1 relaxation; prostate.

MeSH terms

  • Aged
  • Algorithms*
  • Humans
  • Imaging, Three-Dimensional / methods*
  • Magnetic Resonance Spectroscopy / methods*
  • Male
  • Middle Aged
  • Molecular Imaging / methods*
  • Phosphorus Compounds / metabolism*
  • Phosphorus Isotopes / pharmacokinetics
  • Prostate
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / pathology
  • Radiopharmaceuticals / pharmacokinetics
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tissue Distribution

Substances

  • Phosphorus Compounds
  • Phosphorus Isotopes
  • Radiopharmaceuticals